Suchergebnisse - "Wu, Zhigui"

PubPharm (46)

1

Trends in adverse drug reactions between 2011 and 2022 in a tertiary hospital in China through retrospective analysis

enthalten in: ResearchSquare.com | 2024

von Liu, Y. | Yang, L. | Li, T. | +3

2

Secular trend analysis of antibiotic utilisation in some hospitals in western China from 2010 to 2020

enthalten in: ResearchSquare.com | 2023

von Wu, Z. | Li, Y. | Li, R. | +5

3

Role of miR‑181a‑5p in cancer (Review)

enthalten in: International journal of oncology | 2023

von Li, J. | Shen, J. | Zhao, Y. | +7

4

Pharmacological properties and underlying mechanisms of aurantio‑obtusin (Review)

enthalten in: Experimental and therapeutic medicine | 2023

von Liu, Y. | Sun, X. | Hu, X. | +3

5

Secular trend analysis of antibiotic utilisation in some hospitals in Southern Sichuan from 2010 to 2020

enthalten in: Scientific reports | 2023

von Wu, Z. | Li, Y. | Li, R. | +5

6

PROTACs in gastrointestinal cancers

enthalten in: Molecular therapy oncolytics | 2022

von Chen, Y. | Yang, Q. | Xu, J. | +17

7

Comprehensive analysis of chemokines family and related regulatory ceRNA network in lung adenocarcinoma

enthalten in: Heliyon | 2022

von Hu, Y. | Xiao, M. | Zhang, D. | +9

8

New application of berberine

enthalten in: Europäisches Patentamt | 2022

von FU XIAOMEI | WU ZHIGUI | LIU YINGJIAO | +6

9

New application of berberine

enthalten in: Europäisches Patentamt | 2022

von FU XIAOMEI | WU ZHIGUI | LIU YINGJIAO | +6

10

Salvianolic acid B inhibits RAW264.7 cell polarization towards the M1 phenotype by inhibiting NF-κB and Akt/mTOR pathway activation

enthalten in: Scientific reports | 2022

von Zou, T. | Gao, S. | Yu, Z. | +7

1
2
3
4
5
Nächster »
[5]